MCID: RTT001
MIFTS: 41

Ritter's Disease malady

Categories: Skin diseases, Infectious diseases, Rare diseases

Aliases & Classifications for Ritter's Disease

About this section
Sources:
11Disease Ontology, 13DISEASES, 29ICD10, 30ICD10 via Orphanet, 31ICD9CM, 38MeSH, 39MESH via Orphanet, 44NCIt, 49Novoseek, 53Orphanet, 61SNOMED-CT, 67UMLS, 68UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Ritter's Disease:

Name: Ritter's Disease 11 13
Staphylococcal Scalded Skin Syndrome 11 53 49 38 67
Pemphigus Neonatorum 11 67
Toxic Epidermal Necrolysis, Subcorneal Type 11
Dermatitis Exfoliativa Neonatorum 11
 
Generalized Exfoliative Disease 53
Scalded Skin Syndrome 11
Ritter Disease 11
Ssss 53

Characteristics:

Orphanet epidemiological data:

53
staphylococcal scalded skin syndrome:
Age of onset: All ages; Age of death: normal life expectancy

Classifications:



External Ids:

Disease Ontology11 DOID:9063
ICD1029 L00
ICD9CM31 695.81
MeSH38 D013206
NCIt44 C85077
Orphanet53 ORPHA36236
MESH via Orphanet39 D013206
UMLS via Orphanet68 C0038165
ICD10 via Orphanet30 L00

Summaries for Ritter's Disease

About this section
Disease Ontology:11 A commensal bacterial infectious disease that is characterized by widespread erythema, peeling, and necrosis of the skin, that is caused by a toxin produced by a bacterium of the genus Staphylococcus (S. aureus). The infection has symptoms redness of skin, has symptom fluid-filled blister formation, has symptom fever and has symptom irritability.

MalaCards based summary: Ritter's Disease, also known as staphylococcal scalded skin syndrome, is related to dermatitis and impetigo, and has symptoms including fluid-filled blister formation, fever and irritability. An important gene associated with Ritter's Disease is DSG1 (Desmoglein 1), and among its related pathways are Endothelins and Endothelin. Affiliated tissues include skin, prostate and heart, and related mouse phenotype vision/eye.

Related Diseases for Ritter's Disease

About this section

Graphical network of diseases related to Ritter's Disease:



Diseases related to ritter's disease

Symptoms for Ritter's Disease

About this section

Symptoms:

 11
  • fluid-filled blister formation
  • fever
  • irritability

UMLS symptoms related to Ritter's Disease:


coma blister

Drugs & Therapeutics for Ritter's Disease

About this section

Drugs for Ritter's Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 102)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Yohimbineapproved, vet_approvedPhase 427146-48-58969
Synonyms:
(+)-Yohimbin
(+)-Yohimbine
(+)-yohimbine
(16alpha,17alpha)-17-Hydroxy-yohimban-16-carboxylic acid methyl ester
(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester
(16alpha,17alpha)-17-hydroxyyohimban-16-carboxylic acid methyl ester
146-48-5
17-Hydroxy-yohimbane-16-carboxylic acid methyl ester
17-Hydroxyyohimban-16-carboxylic acid methyl ester
17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester
17alpha-hydroxyyohimban-16alpha-carboxylic acid methyl ester
2-Hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydro-indolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylic acid methyl ester
4-25-00-01237 (Beilstein Handbook Reference)
65-19-0
AC1L1S1D
APHRODINE
Actibine
Aphrodine
Aphrodyne
Aphrosol
BCBcMAP01_000032
BPBio1_000472
BRD-K35586044-001-02-6
BRD-K35586044-003-03-0
BRN 0097276
BSPBio_000428
BSPBio_001236
Baron-X
Benz[g]indolo[2,3-a]quinolizine, yohimban-16-carboxylic acid deriv.
Bio1_000455
Bio1_000944
Bio1_001433
Bio2_000458
Bio2_000938
C09256
CHEBI:10093
CHEMBL15245
CID8969
Corynine
D08685
DB01392
Dayto himbin
EINECS 205-672-0
HMS1362N17
HMS1792N17
HMS1990N17
HMS2089G19
I14-13374
IDI1_002213
 
InChI=1/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12?,15?,17?,18-,19+/m0/s
Johimbin
KBio2_000576
KBio2_003144
KBio2_005712
KBio3_001031
KBio3_001032
KBioGR_000576
KBioSS_000576
LS-162738
Lopac0_001210
MLS000728591
MLS001333983
MolPort-001-794-653
NCGC00025018-05
NCGC00025018-06
NCGC00025018-07
NSC19509
Prestwick0_000584
Prestwick1_000584
Prestwick2_000584
Prestwick3_000584
Quebrachin
Quebrachine
SMP1_000320
SMR000058527
SMR000470778
SPBio_002647
STOCK1N-51304
Thybine
UNII-2Y49VWD90Q
Yocon
Yohimar
Yohimban-16-.alpha.-carboxylic acid, 17-.alpha.-hydroxy-, methyl ester
Yohimban-16-alpha-carboxylic acid, 17-alpha-hydroxy-, methyl ester
Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16alpha,17alpha)- (9CI)
Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester (8CI)
Yohimbic acid methyl ester
Yohimbin
Yohimbine
Yohimbine (DCF)
Yohimbol-16alpha-carboxylic acid, methyl ester (6CI)
Yohimex
Yoman
Yovital
methyl (16alpha,17alpha)-17-hydroxyyohimban-16-carboxylate
methyl 17alpha-hydroxyyohimban-16alpha-carboxylate
nchembio.188-comp13
nchembio705-2
trans-Quinolizidine yohimbine
2
Povidone-iodineapprovedPhase 415525655-41-8
Synonyms:
 
Betadine
3
AdalimumabapprovedPhase 4478331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
4
MethotrexateapprovedPhase 4, Phase 215181959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
 
Methopterin
Methotextrate
Methotrate
Methotrexat
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Rheumatrex
Trexall
5
SulfasalazineapprovedPhase 461599-79-15353980, 5359476
Synonyms:
13gs
2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID
2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid
2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid
2-hydroxy-5-(4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl)benzoic acid
2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid
2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid
4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene
5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid
5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid
5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid
5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid
5-(p-(2-Pyridinylsulfamoyl)Phenylazo)Salicylic Acid
5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid
5-(para-(2-pyridylsulfamoyl)phenylazo)salicylic acid
5-22-08-00433 (Beilstein Handbook Reference)
5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid
5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid
5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid
5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid
599-79-1
AC-20497
AC1NS4RK
AC1NSE0P
AC1NTMDP
AC1Q72VB
AKOS002311709
Accucol
Alphapharm Brand of Sulfasalazine
Alti-Sulfasalazine
Ashbourne Brand of Sulfasalazine
Asulfidine
Azlufidine EN-Tabs
Azopyrin
Azopyrine
Azosulfidin
Azulfadine
Azulfidine
Azulfidine (TN)
Azulfidine EN
Azulfidine EN-Tabs
Azulfidine EN-tabs
BIDD:GT0161
BPBio1_000527
BRD-K10670311-001-06-4
BRN 0356241
BSPBio_000479
BSPBio_002888
Benzosulfa
C07316
C18H14N4O5S
CAS-599-79-1
CCRIS 4713
CHEBI:45504
CHEBI:489907
CHEBI:9334
CHEMBL242373
CHEMBL421
CID5353980
CID5359476
CID5384001
CPD000059146
Colo Pleon
Colo-Pleon
D00448
D012460
DB00795
DB08518
DivK1c_000860
EINECS 209-974-3
EN, Azulfidine
FNA Brand of Sulfasalazine
HMS1569H21
HMS1921C05
HMS2051J21
HMS2090P13
HMS2092K07
HMS502K22
HSDB 3395
Henning Berlin Brand of Sulfasalazine
Heyl Brand of Sulfasalazine
I06-0676
IDI1_000860
KBio1_000860
KBio2_001478
KBio2_002314
KBio2_004046
KBio2_004882
KBio2_006614
KBio2_007450
KBio3_002108
KBio3_002794
KBioGR_000753
KBioGR_002314
KBioSS_001478
 
KBioSS_002316
LS-46
MLS000759399
MLS001424109
MolPort-001-792-507
MolPort-003-986-992
NCGC00016518-01
NCGC00090903-01
NCGC00090903-02
NCGC00090903-03
NCGC00090903-04
NCGC00090903-05
NINDS_000860
NSC 203730
NSC 667219
NSC203730
NSC667219
PMS-Sulfasalazine
Pfizer Brand of Sulfasalazine
Pleon
Pms-Sulfasalazine E.C.
Prestwick0_000520
Prestwick1_000520
Prestwick2_000520
Prestwick3_000520
Prestwick_848
Pyralin EN
Ratiopharm Brand of Sulfasalazine
Reupirin
Rorasul
S.A.S. 500
S.A.S. Enteric-500
S.A.S.-500
S0580
SAM001246530
SASP
SBB058178
SI-88
SMP2_000059
SMR000059146
SPBio_001032
SPBio_002400
SPECTRUM1500552
SSZ
ST50767935
Salazo-sulfapyridinum
Salazopiridazin
Salazopyridin
Salazopyrin
Salazopyrin en-tabs
Salazopyrin EN-Tabs
Salazosulfapiridina
Salazosulfapiridina [INN-Spanish]
Salazosulfapyridin
Salazosulfapyridine
Salazosulfapyridine (JP15)
Salazosulfapyridinum
Salazosulfapyridinum [INN-Latin]
Salicylazosulfapyridine
Salisulf
Sanofi Synthelabo Brand of Sulfasalazine
Sas-500
Spectrum2_001216
Spectrum3_001364
Spectrum4_000347
Spectrum5_001443
Spectrum_000998
Sulcolon
Sulfasalazin
Sulfasalazin Heyl
Sulfasalazin medac
Sulfasalazin-Heyl
Sulfasalazina
Sulfasalazina [INN-Spanish]
Sulfasalazine
Sulfasalazine (USP/INN)
Sulfasalazine FNA
Sulfasalazine Pfizer Brand
Sulfasalazine [USAN:INN]
Sulfasalazinum
Sulfasalazinum [INN-Latin]
Sulfazalazine
Sulphasalazine
TL8003811
UNII-3XC8GUZ6CB
Ucine
Ulcol
W-T Sasp Oral
WLN: T6NJ BSWMR DNUNR DQ CVQ
cMAP_000018
medac Brand of Sulfasalazine
nchembio.212-comp9
ratio Sulfasalazine
ratio-Sulfasalazine
sulfasalazine
w-t Sasp oral
6
Etanerceptapproved, investigationalPhase 4397185243-69-0
Synonyms:
185243-69-0
CD120b
D00742
Enbrel
Enbrel (TN)
Enbrel Sureclick
Etanercept
Etanercept (USAN/INN)
 
Etanercept (genetical recombination)
Etanercept (genetical recombination) (JAN)
TNF-R2
Tumor necrosis factor receptor 2
Tumor necrosis factor receptor superfamily member 1B precursor
Tumor necrosis factor receptor type II
etanercept
p75
p80 TNF-alpha receptor
7
Chlorhexidineapproved, vet_approvedPhase 447255-56-19552079, 2713
Synonyms:
1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide]
1,1'-Hexamethylene bis(5-(P-chlorophenyl)biguanide)
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide
1,6-Bis(5-(p-chlorophenyl)biguandino)hexane
1,6-Bis(p-chlorophenyldiguanido)hexane
1,6-Di(4'-chlorophenyldiguanido)hexane
1,6-Di(N-p-chlorophenyldiguanido)hexane
24798_FLUKA
282227_ALDRICH
348031_ALDRICH
4-12-00-01201 (Beilstein Handbook Reference)
55-56-1
AB00053427
AB1003159
AVAGARD
BPBio1_000272
BRN 2826432
BSPBio_000246
BSPBio_001977
C06902
C22H30Cl2N10
CAS-55-56-1
CCRIS 9230
CHEBI:3614
CHEMBL790
CID9552079
Chlorhexidin
Chlorhexidin [Czech]
Chlorhexidine
Chlorhexidine (INN)
Chlorhexidine Base
Chlorhexidine [INN:BAN]
Chlorhexidine gluconate
Chlorhexidinum
Chlorhexidinum [INN-Latin]
Cloresidina
Cloresidina [DCIT]
Clorhexidina
Clorhexidina [INN-Spanish]
D07668
DB00878
Decanoylacetaldehyde Sodium Sulfide
Dentisept [veterinary]
Dentisept [veterinary] (TN)
DivK1c_000761
EINECS 200-238-7
Fimeil
HMS1568M08
HSDB 7196
Hexadol
Hibiclens
Hibispray
Hibistat
I06-0621
I14-0050
IDI1_000761
 
KBio1_000761
KBio2_000717
KBio2_003285
KBio2_005853
KBio3_001197
KBioGR_000774
KBioSS_000717
LS-43917
Lisium (*Dihydrochloride*)
MK-412A
MLS001332387
MLS001332388
MLS002154209
Merfen-incolore
Merfen-incolore (TN)
MolPort-002-541-741
N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NCGC00016246-01
NCGC00091025-01
NCGC00091025-02
NINDS_000761
NSC526936
Nolvasan
Nolvasan (*Diacetate*)
Novalsan
Oro-Clense
Peridex
Periogard
Prestwick0_000143
Prestwick1_000143
Prestwick2_000143
Prestwick3_000143
Prestwick_53
QTL1_000020
Rotersept
SMR000857146
SPBio_000210
SPBio_002185
STK089248
STOCK1S-18831
Savloclens
Savlon babycare
Sebidin A
Sodium Houttuyfonamide
Soretol
Spectrum2_000135
Spectrum3_000339
Spectrum4_000277
Spectrum5_001322
Spectrum_000237
Sterido
Sterilon
Superspray
Tubulicid
UNII-R4KO0DY52L
chlorhexidine
8
HydroxychloroquineapprovedPhase 4146118-42-33652
Synonyms:
(+-)-Hydroxychloroquine
(±)-hydroxychloroquine
118-42-3
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol
2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol
5-22-10-00280 (Beilstein Handbook Reference)
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline
7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
747-36-4 (sulfate (1:1) salt)
AC1L1GEW
BRN 0253894
C07043
C18H26ClN3O
CHEMBL1535
CID3652
D08050
DB01611
DivK1c_000942
EINECS 204-249-8
Gen-Hydroxychloroquine 200mg Tablets
HCQ
HMS502P04
Hidroxicloroquina
 
Hidroxicloroquina [INN-Spanish]
Hydroxychlorochin
Hydroxychloroguine
Hydroxychloroquine (INN)
Hydroxychloroquine Sulfate (1:1) Salt
Hydroxychloroquine [INN:BAN]
Hydroxychloroquinum
Hydroxychloroquinum [INN-Latin]
IDI1_000942
Idrossiclorochina
Idrossiclorochina [DCIT]
KBio1_000942
LS-66614
MolPort-003-847-792
NCGC00159483-02
NINDS_000942
NSC4375
Oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
PlaqueN/A
Polirreumin
Polirreumin (TN)
Quensyl
SPBio_001116
ST072188
Spectrum2_001238
Spectrum5_001697
UNII-4QWG6N8QKH
WIN 1258
hydroxychloroquine
9
Guaifenesinapproved, vet_approvedPhase 461693-14-13516
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
Amonidren
Amonidrin
Aresol
Benylin-E
Bronchol
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
 
Glycerylguaiacol
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphesin
Hustosil
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
O-Methoxyphenyl glyceryl ether
Organidin NR
Pneumomist
Propanosedyl
Reduton
Robitussin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
guaiphenesin
p-Cresyl acetate
10
Folic Acidapproved, nutraceutical, vet_approvedPhase 4, Phase 3427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
11Autonomic AgentsPhase 49774
12Adrenergic AntagonistsPhase 4, Phase 3, Phase 11535
13Adrenergic alpha-AntagonistsPhase 4, Phase 3727
14Adrenergic AgentsPhase 4, Phase 3, Phase 15140
15MydriaticsPhase 4763
16Peripheral Nervous System AgentsPhase 422776
17Anti-Infective AgentsPhase 4, Phase 321402
18Neurotransmitter AgentsPhase 4, Phase 3, Phase 117734
19Anti-Infective Agents, LocalPhase 41785
20Vitamin B ComplexPhase 44229
21Nucleic Acid Synthesis InhibitorsPhase 44855
22Plasma SubstitutesPhase 4233
23MicronutrientsPhase 45802
24PovidonePhase 4157
25Trace ElementsPhase 45802
26
IodinePhase 45467553-56-2807
Synonyms:
I2
Iode
Iodine-molecule
 
Iodio
Iodum
Jod
Jood
Tincture iodine
27DisinfectantsPhase 4547
28cadexomer iodinePhase 4514
29Chlorhexidine gluconatePhase 4472
30Blood SubstitutesPhase 4246
31Immunosuppressive AgentsPhase 4, Phase 312770
32AntimetabolitesPhase 4, Phase 3, Phase 111774
33Antimetabolites, AntineoplasticPhase 4, Phase 3, Phase 17171
34Antiparasitic AgentsPhase 42127
35AntimalarialsPhase 41216
36Anti-Inflammatory Agents, Non-SteroidalPhase 44295
37AnalgesicsPhase 411287
38Analgesics, Non-NarcoticPhase 46260
39Antiprotozoal AgentsPhase 41986
40Anti-Inflammatory AgentsPhase 4, Phase 110355
41Gastrointestinal AgentsPhase 48109
42Folic Acid AntagonistsPhase 42200
43Antirheumatic AgentsPhase 410627
44Chlorpheniramine, phenylpropanolamine drug combinationPhase 4616
45Dermatologic AgentsPhase 45674
46YohimbeNutraceuticalPhase 427
47Folinic AcidNutraceuticalPhase 4, Phase 33150
48FolateNutraceuticalPhase 4, Phase 34279
49Vitamin B9NutraceuticalPhase 4, Phase 34279
50
NorepinephrineapprovedPhase 368351-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
LT03330026
 
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Nor-adrenaline
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024

Interventional clinical trials:

(show all 39)
idNameStatusNCT IDPhase
1Clinical Evaluation on Advanced ResynchronizationCompletedNCT00658203Phase 4
2Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg YohimbineCompletedNCT00975325Phase 4
3Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart FailureCompletedNCT00733343Phase 4
4AAA Registry: Clinical Outcomes of Highly Angulated anatomY Treated With the Aorfix™ Stent GraftRecruitingNCT02480595Phase 4
5Treatments Against RA and Effect on FDG-PET/CTRecruitingNCT02374021Phase 4
6Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device ImplantationRecruitingNCT01841242Phase 4
7Clinical Assessment of the SonR Algorithm in the PARADYM RF SonR CRT-D by EchocardiographyActive, not recruitingNCT01869062Phase 4
8Long-Term Safety Of DVS-233 SR In Patients With Major Depressive DisorderCompletedNCT01309542Phase 3
9Lurasidone Extended Use StudyCompletedNCT01485640Phase 3
10Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)CompletedNCT00868452Phase 3
11Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)CompletedNCT00868699Phase 3
12Lurasidone - A 24-week Extension Study of Patients With Bipolar I DepressionCompletedNCT00868959Phase 3
13Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT DeviceCompletedNCT02167789Phase 3
14Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AMLRecruitingNCT02140242Phase 3
15Tasigna and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER StudyRecruitingNCT01657604Phase 3
16Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction ChemotherapyRecruitingNCT01827553Phase 3
17Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose IntoleranceActive, not recruitingNCT02673749Phase 2, Phase 3
18Continuous Positive Airway Pressure Ventilation After Acute Ischemic StrokeCompletedNCT00151177Phase 1, Phase 2
19Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose IntoleranceCompletedNCT01113619Phase 2
20Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic NodesCompletedNCT00214136Phase 2
21Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate CancerRecruitingNCT02470897Phase 1, Phase 2
22Tepotinib Phase II Study in Lung Adenocarcinoma Harbouring MET Exon 14 (METex14) Skipping AlterationsRecruitingNCT02864992Phase 2
23Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder CancerRecruitingNCT02316548Phase 2
24Phase I/II Hypofractionated Radiotherapy for Prostate CancerActive, not recruitingNCT00214097Phase 1, Phase 2
25Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) PatientsCompletedNCT01103609Phase 1
26A Study Conducted Over 3 Periods to Look at the Drug in the BodyCompletedNCT01225939Phase 1
27Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy SubjectsCompletedNCT01311622Phase 1
28Stereotactic Body Radiation Therapy and Capecitabine Before Surgery in Treating Patients With Pancreatic Cancer That Can be Removed by SurgeryRecruitingNCT01918644Phase 1
29A Study to Evaluate AZP531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes MellitusActive, not recruitingNCT02040012Phase 1
30A Phase 1, First in Human Study to Investigate the Safety and Tolerability of PA401TerminatedNCT01627002Phase 1
31To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic HypertensionTerminatedNCT01403922Phase 1
32A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced MucositisTerminatedNCT01975688Phase 1
33The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)CompletedNCT00822276
34Magnesium Replacement Therapy to Prevent Acute Renal Failure in Critically Ill PatientsCompletedNCT01700998
35Sleep-Disordered Breathing in Heart Failure - The SchlaHF-RegistryCompletedNCT01500759
36Triadyme-C, a Polycrystalline Diamond Compact Cervical Disc Replacement (cTDR)RecruitingNCT02967575
37Impact of Fever Prevention in Brain Injured PatientsRecruitingNCT02996266
38Master Study of the Ilivia ICD Family and the Plexa ICD LeadRecruitingNCT02774616
39Smartphone-based Ambulatory Assessment of Early Warning SignsNot yet recruitingNCT02782910

Search NIH Clinical Center for Ritter's Disease


Cochrane evidence based reviews: staphylococcal scalded skin syndrome

Genetic Tests for Ritter's Disease

About this section

Anatomical Context for Ritter's Disease

About this section

MalaCards organs/tissues related to Ritter's Disease:

35
Skin, Prostate, Heart, Myeloid, Testes, Lung, Brain

Animal Models for Ritter's Disease or affiliated genes

About this section

MGI Mouse Phenotypes related to Ritter's Disease:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053918.3DSG1, EDNRA, EDNRB, HSF4

Publications for Ritter's Disease

About this section

Articles related to Ritter's Disease:

(show all 28)
idTitleAuthorsYear
1
Picture of the month. Ritter's disease (neonatal staphylococcal scalded skin syndrome). (1558075)
1992
2
Nosocomial scalded skin syndrome. Ritter's disease caused by phage group 3 Staphylococcus aureus. (6449146)
1980
3
Atopic dermatitis and Ritter's disease: differential diagnosis by means of total and specific serum IgE. (147160)
1978
4
Toxic epidermal necrolysis (TEN; Ritter's disease) and staphylococcal scalded skin syndrome (SSSS). A description and review. (780034)
1976
5
Total and specific IgE levels as a means of differentiating Ritter's disease from atopic dermatitis. (127536)
1975
6
New type of exfoliatin obtained from staphylococcal strains, belonging to phage groups other than group II, isolated from patients with impetigo and Ritter's disease. (4139120)
1974
7
Epidemic boric acid poisoning simulating staphylococcal toxic epidermal necrolysis of the newborn infant: Ritter's disease. (4251286)
1970
8
Haemolysin and enzyme patterns of coagulase-positive staphylococci isolated from toxic epidermal necrolysis, Ritter's disease and impetigo contagiosa. (4252396)
1969
9
Toxic epidermal necrolysis (the scalded skin syndrome). Its association in two cases with pathogenic staphylococci and its similarity in infancy to Ritter's disease. (4222069)
1966
10
RITTER'S DISEASE. (14291657)
1965
11
Epidemic staphylococcal pyoderma associated with Ritter's disease and the appearance of phage type 3B/71. (13975789)
1963
12
An outbreak of exfoliative dermatitis of the newborn (Ritter's disease) due to Staphylococcus aureus, phage-type 55/71. (13867356)
1962
13
Ritter's disease: exfoliative dermatitis of the newborn. (13869919)
1962
14
An outbreak of Ritter's disease. (13763310)
1961
15
Some interesting but rare disorders seen in pediatric practice with case report of Ritter's disease with recovery. (13502281)
1958
16
Ritter's disease (dermatitis exfoliativa neonatorum) with recovery. (13464996)
1957
17
Dermatitis exfoliativa neonatorum; Ritter's disease. (13468377)
1957
18
Ritter's disease with recovery. (13166184)
1954
19
Impetigo and acute infectious exfoliative dermatitis of the newborn infant (Ritter's disease). (14955740)
1952
20
Ritter's disease and sclerema; report on two rare cases in infants. (14921951)
1952
21
Ritter's disease. (18120097)
1949
22
Ritter's disease; report of a case treated with vitamins and penicillin with recovery. (18101843)
1948
23
Topical and parenteral penicillin therapy in Ritter's disease; report of four cases with recovery. (18101064)
1948
24
Ritter's disease. (18920581)
1948
25
Ritter's disease in fraternal twins, with special reference to the pathogenesis. (20255863)
1947
26
Ritter's disease (dermatitis exfoliativa neonatorum); report of a case. (20275913)
1946
27
A case of exfoliative dermatitis of the newborn (Ritter's disease). (21032230)
1942
28
A CASE OF RITTER'S DISEASE. (20770997)
1923

Variations for Ritter's Disease

About this section

Expression for genes affiliated with Ritter's Disease

About this section
Search GEO for disease gene expression data for Ritter's Disease.

Pathways for genes affiliated with Ritter's Disease

About this section

Pathways related to Ritter's Disease according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.5EDNRA, EDNRB
29.5EDNRA, EDNRB
39.5EDNRA, EDNRB

GO Terms for genes affiliated with Ritter's Disease

About this section

Cellular components related to Ritter's Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1lateral plasma membraneGO:00163289.5DSG1, DSG2
2desmosomeGO:00300578.6DSG1, DSG2, DSG4

Biological processes related to Ritter's Disease according to GeneCards Suite gene sharing:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1endothelin receptor signaling pathwayGO:008610010.2EDNRA, EDNRB
2regulation of epithelial cell proliferationGO:005067810.1EDNRA, EDNRB
3enteric nervous system developmentGO:004848410.1EDNRA, EDNRB
4vasoconstrictionGO:004231010.1EDNRA, EDNRB
5response to progesteroneGO:003257010.1DSG1, DSG2
6maternal process involved in female pregnancyGO:006013510.0DSG1, DSG2
7sensory perception of painGO:00192339.7EDNRA, EDNRB
8regulation of blood pressureGO:00082179.7EDNRA, EDNRB
9positive regulation of cytosolic calcium ion concentrationGO:00072049.7EDNRA, EDNRB
10single organismal cell-cell adhesionGO:00163379.6DSG1, DSG4
11positive regulation of cell proliferationGO:00082848.7EDNRA, EDNRB, HSF4
12homophilic cell adhesion via plasma membrane adhesion moleculesGO:00071568.6DSG1, DSG2, DSG4

Molecular functions related to Ritter's Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endothelin receptor activityGO:000496210.2EDNRA, EDNRB
2calcium ion bindingGO:00055098.9DSG1, DSG2, DSG4

Sources for Ritter's Disease

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet